2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

LATE ONSET OF PARKINSON’S DISEASE

I. Smolentseva, N. Amosova, A. Kuzmina (Moscow, Russian Federation)
Left STN DBS And Right CZI DBS In A Patient With Tremor-Predominant Parkinson’s Disease

T. Ali, D. Ginjupally, G. Quintero, C. van Horne, Z. Guduru (Lexington, KY, USA)
Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

S. Joza, F. Ba (Edmonton, AB, Canada)
Levodopa Effects on Visuospatial Working Memory in Parkinson’s Disease

E. Bayram, I. Litvan, B. Wright, C. Grembowski, D. Harrington (La Jolla, CA, USA)
Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor

I. Zhukova, N. Zhukova, E. Kolupaeva, S. Ivanova, M. Nikitina, O. Izhboldina, I. Mironova (Tomsk, Russian Federation)
Levodopa response in later stages of Parkinson’s disease: a case-control study

M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)
Levodopa-carbidopa intestinal gel infusion: a video analysis of long-term effect on gait and posture

C. Pongmala, M. Fabbri, CA. Artusi, M. Zibetti, L. Lopiano (Turin, Italy)
Levodopa-responsive tremor in a young child as a delayed complication of osmotic demyelination from severe hypernatremia

L. Tochen, M. Cameron, C. Brady, M. Fleming (Washington, DC, USA)
Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

W. Kamel, J. Al Hashel (Beni Suef, Egypt)
Life expectancy with and without Parkinson’s disease in the general population

L. Dommershuijsen, A.. Ikram, K. Ikram (Rotterdam, Netherlands)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z